WX

WebserviceX

Agentic AI Equity Research

Coverage blotter·Stock analysis hub·Note 2026-07-20·Latest →

Medtronic (MDT) Stock Analysis

OW

MDT Equity Research — OVERWEIGHT — July 2026

← LLYMRK →

Rating date

Jul 20, 2026

21 days ago

Desk view

OW

5D move

—

Awaiting market data

Peer rank

49p

Research history

2026-08-072026-07-202026-07-012026-06-252026-06-182026-06-162026-06-082026-06-02+1 more

Investment card · MDT

Here is the analysis of MDT (Medtronic) as of 2026-07-20.

Desk rating

OW

Tactical OW · 12M OW

Horizon

Long-term

Confidence

Low

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Bias

OVERWEIGHT

Catalysts

  • MDT is in a confirmed long-term downtrend — price below the 200-day SMA and the 50-day SMA far below the 200-day SMA constitute a classic bearish structure.
  • A short-term recovery bounce is underway — price has reclaimed the 50-day SMA and MACD is accelerating higher, indicating buying interest.
  • RSI is neutral — there is ample room for the bounce to continue before reaching overbought territory (70+).

Risks

  • Event-driven repricing risk if expectations diverge from incoming evidence.

Market chart

Price context alongside the research narrative.

MDT Research Note

Full desk note for Jul 20, 2026. Use tabs for catalysts, valuation and risks, or open the full note.

22 min read

WebserviceX · Agentic Research Desk

MDT Equity Research Note

Published Jul 20, 2026 · Desk view OVERWEIGHT · Generated 2026-07-21T15:42:48Z · Maintained by Walter Vijayakumar · Methodology · Track record

MDT Stock Rating Summary

MDT bias

OVERWEIGHT

Horizon

Long-term

MDT key risk

Event-driven repricing risk if expectations diverge from incoming evidence.

MDT catalyst watch

MDT is in a confirmed long-term downtrend — price below the 200-day SMA and the 50-day SMA far below the 200-day SMA constitute a classic bearish structure.

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Confidence

Low

How the call aged · 5D

—Awaiting market dataPeer 49p
Expand

Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-07-21T15:52:29.888992+00:00.

5D move

—

2026-07-20 → awaiting

Outcome

Awaiting market data

5D trend

-0.34%

Vol (20D ann.)

+34.46%

vs SPY: +0.61%

Close 83.29 → — (USD, vendor closes)

Batch scorecard · 2026-07-20 · MDT

Publish QC

passed
Expand

Pipeline fingerprint 2f45a102687f75c0

Trace 39ed27d0…

No QC issues recorded.